CL
SGYP

CSS LLC’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CSS LLC’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,852
Closed -$49K – 818
2016
Q2 		$49K Sell
12,852
-138,450
-92% -$469K ﹤0.01% 663
2016
Q1 		$418K Buy
+151,302
New +$548K 0.03% 367

Other funds holding SGYP

TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CSS LLC's SGYP Position: Q3 2016 in Review

CSS LLC sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016, closing a stake of 12,852 shares — an estimated $49K sold.

CSS LLC first reported a position in SGYP in Q1 2016 and held it in 2 quarters. The position peaked at $418K in Q1 2016. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

  • CSS LLC reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2016 after selling out during the quarter.
  • CSS LLC sold 12,852 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $49K.
  • CSS LLC first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2016 and held it in 2 quarters.
  • CSS LLC's Synergy Pharmaceuticals, Inc Common Stock position peaked at $418K in Q1 2016.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on CSS LLC's 13F filing for Q3 2016, filed 14 Nov 2016.